Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
A closer look at MS, NMOSD AND MOGAD, following the event organised by the European Charcot Foundation
Written by Anna Revilla, Membership and Community Engagement Coordinator Have you ever heard of NMOSD or MOGAD? Did you know…
EMSP Addresses MEP Interest Group on Critical MS Challenges in Europe
Elisabeth Kasilingam, CEO of the European Multiple Sclerosis Platform (EMSP), spoke at the MEP Interest Group on Brain Health and…
Could the Epstein-Barr Virus hold the key for treatment and prevention of MS? BEHIND-MS Explores New Research Frontier
This week, leading researchers, clinicians, and patient advocates gathered in Heidelberg for the first annual meeting of the BEHIND-MS…
EMSP Advocates for Patient-Centered AI Development at Brain Innovation Days 2024
EMSP CEO, Elisabeth Kasilingam, joined leading experts at the Brain Innovation Days in Brussels on November 23-24 to discuss the…
EMSP at ECTRIMS 2024 – Key takeaways
EMSP delegates actively participated in the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis ECTRIMS…
ΠουΣ App: Empowering MS Patients for Better Symptom Management
Managing symptoms of Multiple Sclerosis (MS) can significantly enhance patients’ quality of life. These symptoms may include fatigue, muscle weakness,…
